# Heart Failure Polypill at a Safety Net Hospital

> **NCT06029712** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 35 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction
- HIV Infections

## Interventions

- **DRUG:** Heart failure polypill
- **DRUG:** Control Rx

## Key facts

- **NCT ID:** NCT06029712
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-27
- **Primary completion:** 2024-09-17
- **Final completion:** 2025-01-29
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06029712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06029712, "Heart Failure Polypill at a Safety Net Hospital". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06029712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*